BioSpace News Archive

HHS found nearly half of NIH clinical trials were reported incorrectly, in violation of federal standards, according to a new report issued Friday by the agency.

Novartis’ canakinumab failed again in non-small cell lung cancer while Anixa Biosciences, Palisade Bio and Genexine kicked off new trials.

Over the years, biomedical researchers have increasingly focused on developing efficient and reliable methods for precise and targeted changes to virtually any point of genome of any living cell.

The virology specimen collection market has been anticipated to grow at a noticeable pace in the years to come.

According to Transparency Market Research’s latest research report on the global bone graft substitutes market for the historical year, base year, and the forecast period, rise in prevalence of bone and joint disorders, technological advancements, increase in government initiatives for joint replacement surgeries, and surge in the number of healthcare facilities are projected to drive the global bone graft substitutes market in the near future.

The conventional low-priced mainstay drugs for the treatment of malaria, sulphadoxine-pyrimethamine and chloroquine, are witnessing a decline in sales, as they are becoming comparatively ineffective.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Osteoarthritis is a degenerative joint problem and the most widely recognized kind of joint pain.

By Region, Asia Pacific Is Expected To Be A Lucrative Region For Medical Bed Suppliers Driven By Developing Healthcare Infrastructure In Various Emerging Economies

At Medivir’s AGM on May 5, Uli Hacksell, Lennart Hansson, Bengt Westermark and Yilmaz Mahshid were re-elected and Anette Lindqvist was newly elected as board members in the company. Uli Hacksell was re-elected as chairman of the board. An van Es Johansson had declined re-election.

Skanska and the Kronoberg Region have signed an agreement on phase one of the work on Växjö’s new emergency hospital.